EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische Studie

Repeated‐dose behavioral intervention to reduce opioid overdose among overdose survivors with opioid use disorder: A two‐site phase III randomized controlled trial

Phillip O Coffin iD, Glenn-Milo Santos, Vanessa M McMahan, Xochitl Luna Marti, Tim Matheson, Sarah Brennan, Justine Arenander, Mackenzie Robinson, John Farley, Emily Pope, Andrew Rolles, Sarah Kosakowski und 2 weitere

Addiction · 2026

DOI: 10.1111/add.70252 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Addiction, 2026. Verfasst von Phillip O Coffin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center on Substance Use and Health, San Francisco Department of Public Health, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Opiate Overdose, Motivational Interviewing, Drug Overdose. Die Arbeit nennt 37 Literaturangaben. Gefördert von: NIAAA NIH HHS, NIDA NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims The emergence of fentanyl in the street market for opioids has limited the benefits of some interventions to manage opioid overdose; thus, preventing the occurrence of opioid overdose is essential. We tested a behavioral intervention shown to prevent heroin overdose in a pilot study, in two United States cities with prevalent fentanyl.

Design

Phase III two‐site single‐blinded randomized controlled trial of a repeated dose motivational interviewing intervention to reduce overdose (REBOOT) versus attention control, over 16 months from 2019 to 2023.

Setting

San Francisco, California, and Boston, Massachusetts, USA.

Participants

18–65 years of age, with opioid use disorder (OUD), active non‐prescribed opioid use, opioid overdose within 3 years and prior receipt of take‐home naloxone. A total of 268 participants were randomized (50% intervention, 50% control), 62% of whom were male, 15% Latine, 65% White and 14% Black/African American; 95% had used fentanyl.

Intervention

Motivational interviewing review of experienced and witnessed overdose and development of personal prevention plan, administered at months 0, 4, 8 and 12.

Measurements

TimeLine FollowBack of interval overdose events and covariates, administered prior to the intervention at months 0, 4, 8, 12 and 16. Primary outcome was occurrence of any nonfatal or fatal overdose event.

Findings

There were no significant effects of REBOOT compared with control on the primary outcome of occurrence of any overdose [relative risk (RR) = 0.94, 95% confidence interval (CI) = 0.79–1.11, P = 0.45] or secondary outcome of the number of overdose events (RR = 0.80, 95% CI = 0.6–1.06, P = 0.12). Results did not differ when excluding data collected during the first 12 months of the COVID‐19 pandemic. Compared with control, REBOOT was not associated with days in OUD treatment and not using opioids (RR = 0.94, 95% CI = 0.88–1.00, P = 0.06). In post‐hoc analysis, REBOOT was associated with fewer overdose events among participants with no past 4‐month overdose at baseline (RR = 0.70, 95% CI = 0.51–0.97, P = 0.03).

Conclusion

A repeated dose motivational interviewing intervention to reduce overdose had no statistically significant effect on opioid overdose in two US cities where fentanyl was the dominant street opioid.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Opioid-Related DisordersOpiate OverdoseMotivational InterviewingDrug OverdoseHumansMaleAdultFemaleMiddle AgedYoung AdultSingle-Blind MethodAdolescentFentanylAnalgesics, OpioidAgedSan FranciscoBoston

Stichwörter der Autor:innen

Boston and San Franciscobehavioral interventionfentanylmotivational interviewingopioid overdoserandomized controlled trial

Substanzen

FentanylAnalgesics, Opioid

Autor:innen und Institutionen

  • Center on Substance Use and Health, San Francisco Department of Public Health, San Francisco, CA, USA.
  • University of California San Francisco, San Francisco, CA, USA.
  • Boston Medical Center, Boston, MA, USA.
  • Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.

ORCID-Profile: Phillip O Coffin

Förderung

  • NIAAA NIH HHS
  • NIDA NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Coffin, P. O., Santos, G. M., McMahan, V. M., Luna Marti, X., Matheson, T., Brennan, S., Arenander, J., Robinson, M., Farley, J., Pope, E., Rolles, A., Kosakowski, S., Green, T. C., & Walley, A. Y. (2026). Repeated‐dose behavioral intervention to reduce opioid overdose among overdose survivors with opioid use disorder: A two‐site phase III randomized controlled trial. Addiction. https://doi.org/10.1111/add.70252

Vancouver

Coffin PO, Santos GM, McMahan VM, Luna Marti X, Matheson T, Brennan S, et al. Repeated‐dose behavioral intervention to reduce opioid overdose among overdose survivors with opioid use disorder: A two‐site phase III randomized controlled trial. Addiction. 2026. doi:10.1111/add.70252

BibTeX
@article{Coffin2026,
  author = {Coffin, Phillip O and Santos, Glenn-Milo and McMahan, Vanessa M and Luna Marti, Xochitl and Matheson, Tim and Brennan, Sarah and Arenander, Justine and Robinson, Mackenzie and Farley, John and Pope, Emily and Rolles, Andrew and Kosakowski, Sarah and Green, Traci C and Walley, Alexander Y},
  title = {Repeated‐dose behavioral intervention to reduce opioid overdose among overdose survivors with opioid use disorder: A two‐site phase III randomized controlled trial},
  journal = {Addiction},
  year = {2026},
  doi = {10.1111/add.70252}
}
Kostenlos starten →